Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer
Beatriz E. Adrada(The University of Texas MD Anderson Cancer Center), Gaiane M. Rauch(The University of Texas MD Anderson Cancer Center), Gary J. Whitman(The University of Texas MD Anderson Cancer Center), Peng Wei(Creighton University), Anil Korkut, Jennifer K. Litton(The University of Texas MD Anderson Cancer Center), Banu Arun(The University of Texas Health Science Center at Houston), Kelly K. Hunt(The University of Texas MD Anderson Cancer Center), Jason B. White(The University of Texas MD Anderson Cancer Center), Alastair M. Thompson(Baylor College of Medicine), Rania M. Mohamed(The University of Texas MD Anderson Cancer Center), Jessica W. T. Leung(The University of Texas MD Anderson Cancer Center), Miral Patel(The University of Texas MD Anderson Cancer Center), Deanna L. Lane(The University of Texas MD Anderson Cancer Center), Stacy L. Moulder(The University of Texas MD Anderson Cancer Center), Sanaz Pashapoor(The University of Texas MD Anderson Cancer Center), Mary S. Guirguis(The University of Texas MD Anderson Cancer Center), Clinton Yam(The University of Texas MD Anderson Cancer Center), Rosalind P. Candelaria(The University of Texas MD Anderson Cancer Center), Tanya W. Moseley(The University of Texas MD Anderson Cancer Center), Huong T. Le‐Petross(The University of Texas MD Anderson Cancer Center), Vicente Valero(The University of Texas MD Anderson Cancer Center), Wei Yang(Shanghai Jiao Tong University), Jingfei Ma(The University of Texas MD Anderson Cancer Center), Jia Sun(The University of Texas MD Anderson Cancer Center), Nour Abuhadra(Memorial Sloan Kettering Cancer Center), Debu Tripathy(The University of Texas MD Anderson Cancer Center), Lei Huo(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Association analysis identifies 65 new breast cancer risk loci
|Nature|2017|1.6k
The chromatin accessibility landscape of primary human cancers
|Science|2018|1.4k
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k